UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$91.22K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 4, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$518.68
Aug 4, 2026
Close before public filing
$518.68
Aug 4, 2026
Return since public filing
-4.16%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 178 shares @ $512.49
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000113
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$6.2M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 4, 2026 | $1.29M |
| United Therapeutics Corp UTHR Current | Sale | Aug 4, 2026 | $91.22K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $93.44K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $347.24K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $311.88K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $1.27M |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $1.63M |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $749.6K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $268.58K |
| United Therapeutics Corp UTHR | Sale | Aug 4, 2026 | $155.63K |
| United Therapeutics Corp UTHR | Exercise | Aug 4, 2026 | $0 |